<DOC>
	<DOCNO>NCT00149422</DOCNO>
	<brief_summary>The purpose study determine whether NT-proBNP guide treatment chronic congestive heart failure reduce heart failure relate morbidity mortality compare therapy guide standard clinical judgement .</brief_summary>
	<brief_title>Effect NT-proBNP Guided Treatment Chronic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Admission congestive heart failure Elevated NTproBNP level admission Lifethreatening cardiac arrhythmia Urgent intervention Severe lung disease Presence life threaten disease Signed informed consent study Mental physical status allow write informed consent . Unwillingness give inform consent Patients undergoing haemodialysis continuous ambulatory peritoneal dialysis ( CAPD )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>NT-proBNP</keyword>
</DOC>